Early Antenatal Prediabetes: A Critical Red Flag for Rapid Postpartum Progression to Type 2 Diabetes

Early Antenatal Prediabetes: A Critical Red Flag for Rapid Postpartum Progression to Type 2 Diabetes

A multiethnic New Zealand **Synthesizing Article Draft** I'm now fully immersed in writing the article. I'm focusing on the "Introduction/Highlight," integrating the essential findings regarding HbA1c, BMI, and Pacific ethnicity as predictors. I'm expanding on the study's design and findings, specifically the lipid profiling and its role in distinguishing between T2D and GCK-MODY. Finally, the thumbnail prompt is being incorporated. study reveals that women with early antenatal prediabetes face a significantly higher risk of rapid postpartum progression to type 2 diabetes compared to those with traditional gestational diabetes, highlighting the clinical value of booking HbA1c for risk stratification.
Transitioning to Tubeless Automated Insulin Delivery: Clinical Insights from the RADIANT Trial and Contemporary Management of Type 1 Diabetes

Transitioning to Tubeless Automated Insulin Delivery: Clinical Insights from the RADIANT Trial and Contemporary Management of Type 1 Diabetes

This review synthesizes the landmark RADIANT trial findings, demonstrating the efficacy of transitioning patients from multiple daily injections to tubeless automated insulin delivery, while integrating broader evidence on genetic susceptibility and metabolic comorbidity management.

European Perioperative Diabetes Care: Significant Practice Variation Impacts 30-Day Recovery Outcomes

The MOPED study of over 6,000 European patients reveals significant international variations in perioperative diabetes management. Findings demonstrate that higher preoperative HbA1c levels and practice inconsistencies are linked to fewer days at home within 30 days of surgery, highlighting an urgent need for clinical harmonization.